Publication: Bicyclic alpha-Iminophosphonates as High Affinity Imidazoline I-2 Receptor Ligands for Alzheimer's Disease
| dc.contributor.author | Abas, Sonia | |
| dc.contributor.author | Rodriguez-Arevalo, Sergio | |
| dc.contributor.author | Bagan, Andrea | |
| dc.contributor.author | Grinan-Ferre, Christian | |
| dc.contributor.author | Vasilopoulou, Foteini | |
| dc.contributor.author | Brocos-Mosquera, Iria | |
| dc.contributor.author | Muguruza, Carolina | |
| dc.contributor.author | Perez, Belen | |
| dc.contributor.author | Molins, Elies | |
| dc.contributor.author | Javier Luque, F | |
| dc.contributor.author | Perez-Lozano, Pilar | |
| dc.contributor.author | de Jonghe, Steven | |
| dc.contributor.author | Daelemans, Dirk | |
| dc.contributor.author | Naesens, Lieve | |
| dc.contributor.author | Brea, Jose | |
| dc.contributor.author | Isabel Loza, M | |
| dc.contributor.author | Hernández-Hernández, Elena | |
| dc.contributor.author | Garcia-Sevilla, Jesus A | |
| dc.contributor.author | Julia Garcia-Fuster, M | |
| dc.contributor.author | Radan, Milica | |
| dc.contributor.author | Djikic, Teodora | |
| dc.contributor.author | Nikolic, Katarina | |
| dc.contributor.author | Pallas, Merce | |
| dc.contributor.author | Callado, Luis F | |
| dc.contributor.author | Escolano, Carmen | |
| dc.date.accessioned | 2024-09-13T09:11:40Z | |
| dc.date.available | 2024-09-13T09:11:40Z | |
| dc.date.issued | 2020-04-09 | |
| dc.description.abstract | Imidazoline I-2 receptors (I-2-IR), widely distributed in the CNS and altered in patients that suffer from neurodegenerative disorders, are orphans from a structural point of view, and new I-2-IR ligands are urgently required for improving their pharmacological characterization. We report the synthesis and three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of a new family of bicyclic alpha-iminophosphonates endowed with relevant affinities for human brain I-2-IR. Acute treatment in mice with a selected compound significantly decreased Fas-associated protein with death domain (FADD) in the hippocampus, a key signaling mediator of neuroprotective actions. Additionally, in vivo studies in the familial Alzheimer's disease 5xFAD murine model revealed beneficial effects in behavior and cognition. These results are supported by changes in molecular pathways related to cognitive decline and Alzheimer's disease. Therefore, bicyclic alpha-iminophosphonates are tools that may open new therapeutic avenues for I-2-IR, particularly for unmet neurodegenerative conditions. | en |
| dc.description.sponsorship | We strongly acknowledge the advice of Dr. Andres G. Fernandez (our mentor in the CaixaImpulse 2018 program) for invaluable advice. This study was supported by the Ministerio de Economia y Competitividad of Spain (SAF2016-77703) and the Basque Government (IT1211-19). The project leading to these results has received funding from la Caixa Foundation (ID 100010434) under agreement CI18-00002. This activity has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union's Horizon 2020 research and innovation programme. C.G.-F, F.V., C.E., S.R.-A., A.B., and M.P. belong to 2017SGR106 (Generalitat de Catalunya). J.A.G.-S. is a member emeritus of the Institut d'Estudis Catalans. Financial support was provided for F.V. (University of Barcelona, APIF_ 2017), S.R.-A. (Generalitat de Catalunya, 2018FI_B_ 00227), A. B. (Institute of Biomedicine UB_2018), C.M. (Marie Sklodowska-Curie Actions Individual Fellowships H2020-MSCA-IF-2016, ID747487), and E.H.-H. (Consejeria de Innovacion, Investigacion y Turismo del Gobierno de las Islas Baleares y del Fondo Social Europeo, FPI/2102/2018). F.J.L. acknowledges the financial support from the Spanish Ministerio de Economia, Industria y Competitividad (grant MDM-2017-0767; AEI/FEDER UE), and Generalitat de Catalunya (grant 2017SGR1746). M.R., T.D., and K.N. kindly acknowledge Ministry of Science and Technological Development of the Republic of Serbia, Project Contract No. 172033, and HORISON2020-COST-Action CA18133 ERNEST: European Research Network on Signal Transduction. | es_ES |
| dc.format.number | 7 | es_ES |
| dc.format.page | 3610-3633 | es_ES |
| dc.format.volume | 63 | es_ES |
| dc.identifier.citation | Abas Sonia, Rodriguez-Arevalo Sergio, Bagan Andrea, Grinan-Ferre Christian, Vasilopoulou Foteini, Brocos-Mosquera Iria, et al. Bicyclic alpha-Iminophosphonates as High Affinity Imidazoline I-2 Receptor Ligands for Alzheimer's Disease. J Med Chem. 2020 Apr 09;63(7):3610-3633. Epub 2020 Mar 19. | en |
| dc.identifier.doi | 10.1021/acs.jmedchem.9b02080 | |
| dc.identifier.e-issn | 1520-4804 | es_ES |
| dc.identifier.issn | 0022-2623 | |
| dc.identifier.journal | Journal of Medicinal Chemistry | es_ES |
| dc.identifier.other | http://hdl.handle.net/20.500.13003/11009 | |
| dc.identifier.pubmedID | 32150414 | es_ES |
| dc.identifier.pui | L2005687973 | |
| dc.identifier.scopus | 2-s2.0-85083077827 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/22847 | |
| dc.identifier.wos | 526405300015 | |
| dc.language.iso | eng | en |
| dc.publisher | American Chemical Society (ACS) | |
| dc.relation.publisherversion | https://dx.doi.org/10.1021/acs.jmedchem.9b02080 | en |
| dc.rights.accessRights | open access | en |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.decs | Animales | * |
| dc.subject.decs | Imidazoles | * |
| dc.subject.decs | Nootrópicos | * |
| dc.subject.decs | Organofosfonatos | * |
| dc.subject.decs | Células de Riñón Canino Madin Darby | * |
| dc.subject.decs | Reacción de Cicloadición | * |
| dc.subject.decs | Femenino | * |
| dc.subject.decs | Ligandos | * |
| dc.subject.decs | Perros | * |
| dc.subject.decs | Células Vero | * |
| dc.subject.decs | Células HeLa | * |
| dc.subject.decs | Receptores de Imidazolina | * |
| dc.subject.decs | Relación Estructura-Actividad Cuantitativa | * |
| dc.subject.decs | Humanos | * |
| dc.subject.decs | Hipocampo | * |
| dc.subject.decs | Chlorocebus aethiops | * |
| dc.subject.decs | Enfermedad de Alzheimer | * |
| dc.subject.decs | Ratones | * |
| dc.subject.decs | Estructura Molecular | * |
| dc.subject.mesh | Alzheimer Disease | * |
| dc.subject.mesh | Molecular Structure | * |
| dc.subject.mesh | Organophosphonates | * |
| dc.subject.mesh | Quantitative Structure-Activity Relationship | * |
| dc.subject.mesh | Hippocampus | * |
| dc.subject.mesh | Humans | * |
| dc.subject.mesh | Vero Cells | * |
| dc.subject.mesh | Chlorocebus aethiops | * |
| dc.subject.mesh | HeLa Cells | * |
| dc.subject.mesh | Cycloaddition Reaction | * |
| dc.subject.mesh | Madin Darby Canine Kidney Cells | * |
| dc.subject.mesh | Ligands | * |
| dc.subject.mesh | Dogs | * |
| dc.subject.mesh | Female | * |
| dc.subject.mesh | Animals | * |
| dc.subject.mesh | Imidazoles | * |
| dc.subject.mesh | Nootropic Agents | * |
| dc.subject.mesh | Imidazoline Receptors | * |
| dc.subject.mesh | Mice | * |
| dc.title | Bicyclic alpha-Iminophosphonates as High Affinity Imidazoline I-2 Receptor Ligands for Alzheimer's Disease | en |
| dc.type | research article | en |
| dc.type.hasVersion | SMUR | es_ES |
| dspace.entity.type | Publication | |
| relation.isPublisherOfPublication | 226dc880-a160-4773-8f02-d8d2680f07d3 | |
| relation.isPublisherOfPublication.latestForDiscovery | 226dc880-a160-4773-8f02-d8d2680f07d3 |


